• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.20% Nasdaq Down0.17%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    8.58 Up 0.19(2.26%) 4:00PM EDT
    |After Hours : 8.58 0.00 (0.00%) 4:48PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 5,167   2,457   1,840   3,802  
    Cost of Revenue -   -   -   -  
    Gross Profit 5,167   2,457   1,840   3,802  
    Operating Expenses
    Research Development9,426  9,244  7,018  9,607  
    Selling General and Administrative4,108  4,224  3,154  4,347  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (8,368) (11,012) (8,331) (10,153)
    Income from Continuing Operations
    Total Other Income/Expenses Net137  257  (17)893  
    Earnings Before Interest And Taxes(8,231)(10,755)(8,348)(9,260)
    Interest Expense -   -   -   -  
    Income Before Tax(8,231)(10,755)(8,348)(9,260)
    Income Tax Expense -   -   -   -  
    Minority Interest1  1  1  6  
    Net Income From Continuing Ops(10,582)(7,411)(7,178)(10,711)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (10,582) (7,411) (7,178) (10,711)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (10,582) (7,411) (7,178) (10,711)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.